#MedSafetyWeek from November 6 to 12, 2023 - Reporting suspected adverse drug reactions helps to improve the safety of medicines. In a joint "MedSafetyWeek" campaign, pharmaceutical authorities around the world are reminding people how important it is to report suspected cases of adverse drug reactions. This year's campaign focuses on the important role of healthcare professionals and patients, who contribute to the safety of medicines by reporting suspected side effects.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

CHESSMEN Board meets in Rome to discuss shortage prevention.

BASG informs about current developments and necessary measures in case of counterfeiting of the medicinal product Ozempic® in German presentation.

With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.